Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 8Pancreatic Neoplasms 6Uterine Cervical Neoplasms 4Neoplasms 4Brain Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Liver Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia 2Hodgkin Disease 2Glioma 2Esophageal Neoplasms 2Disease 2Colonic Neoplasms 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Thoracic Neoplasms 1Thoracic Diseases 1Spinal Diseases 1

Interventions

olaparib 1cabazitaxel 1Prednisone 1Magnetic Resonance Imaging 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostate Cancer, Hereditary, 7 × Magnetic Resonance Imaging × 1 year × Clear all
NCT05384002 2026-06-04

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Fondazione del Piemonte per l'Oncologia

Completed
14,000 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡